Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rod Jackson

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Journal of Primary Health Care|June 1, 2011
Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15)Suneela Mehta, Sue Wells, Tania Riddell, et al.
BMJ (Clinical Research Ed.)|May 29, 2014
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary careVanessa Selak, C Raina Elley, Chris Bullen, et al.
European Heart Journal Open|August 3, 2022
Prediction of first cardiovascular disease event in 2.9 million individuals using Danish administrative healthcare data: a nationwide, registry-based derivation and validation studyDaniel Mølager Christensen, Matthew Phelps, Thomas Gerds, et al.
Plos One|June 8, 2011
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk, Anthony Rodgers, Anushka Patel, et al.
Geroscience|November 11, 2021
Cardiovascular risk prediction in healthy older peopleJohannes T Neumann, Le T P Thao, Emily Callander, et al.
Circulation. Cardiovascular Quality and Outcomes|January 15, 2015
Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trialDavid Peiris, Tim Usherwood, Kathryn Panaretto, et al.
Ebiomedicine|July 19, 2022
Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populationsZhenqiang Wu, Anna P Pilbrow, Oi Wah Liew, et al.
Lancet (London, England)|June 5, 2021
Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation studyRomana Pylypchuk, Sue Wells, Andrew Kerr, et al.
International Journal of Epidemiology|December 22, 2015
Cohort Profile: The PREDICT Cardiovascular Disease Cohort in New Zealand Primary Care (PREDICT-CVD 19)Sue Wells, Tania Riddell, Andrew Kerr, et al.
Journal of Clinical Epidemiology|November 25, 2022
Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issuesYing Wang, Maryam Ghadimi, Qi Wang, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Journal of Primary Health Care|June 1, 2011
Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15)Suneela Mehta, Sue Wells, Tania Riddell, et al.
BMJ (Clinical Research Ed.)|May 29, 2014
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary careVanessa Selak, C Raina Elley, Chris Bullen, et al.
European Heart Journal Open|August 3, 2022
Prediction of first cardiovascular disease event in 2.9 million individuals using Danish administrative healthcare data: a nationwide, registry-based derivation and validation studyDaniel Mølager Christensen, Matthew Phelps, Thomas Gerds, et al.
Plos One|June 8, 2011
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk, Anthony Rodgers, Anushka Patel, et al.
Geroscience|November 11, 2021
Cardiovascular risk prediction in healthy older peopleJohannes T Neumann, Le T P Thao, Emily Callander, et al.
Circulation. Cardiovascular Quality and Outcomes|January 15, 2015
Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trialDavid Peiris, Tim Usherwood, Kathryn Panaretto, et al.
Ebiomedicine|July 19, 2022
Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populationsZhenqiang Wu, Anna P Pilbrow, Oi Wah Liew, et al.
Lancet (London, England)|June 5, 2021
Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation studyRomana Pylypchuk, Sue Wells, Andrew Kerr, et al.
International Journal of Epidemiology|December 22, 2015
Cohort Profile: The PREDICT Cardiovascular Disease Cohort in New Zealand Primary Care (PREDICT-CVD 19)Sue Wells, Tania Riddell, Andrew Kerr, et al.
Journal of Clinical Epidemiology|November 25, 2022
Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issuesYing Wang, Maryam Ghadimi, Qi Wang, et al.
Pageof 20